ArticleJournal for immunotherapy of cancer2025

Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma.

Zena N Willsmore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.